Skip to main content
. 2017 Jul 12;21(12):3579–3591. doi: 10.1111/jcmm.13268

Figure 6.

Figure 6

The inhibition of AKT‐MMP‐2/9 by shRictor was consistent with that by the AKT inhibitor MK‐2206. (A) treatment with MK‐2206 disrupted the channels formation in 3D cultures (**P < 0.05,**P < 0.01). (B) MK‐2206 induced a decrease in the phosphorylation of AKT Ser473 and Thr308 and the expression of MMP‐2/9 (*P < 0.05). (C) the activity of MMP‐2 and MMP‐9 secreted by cells treated with different concentrations of MK‐2206 was detected by Zymography assay.